Skip to content
DataLookout
Menu

NCT07143487

Family Communications After Genetic Testing

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial sites expanded: 360 → 365 locations
  2. Notable Eligibility criteria expanded, about 16 words
    • Trial sites expanded: 319 → 360 locations
    • Study description revised
  3. Minor Trial sites expanded: 299 → 319 locationsv6
  4. Minor Trial sites expanded: 276 → 299 locationsv5
  5. Minor Trial sites expanded: 242 → 276 locationsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 5, 2025 to Apr 6, 2026
    • Study sites: 0 to 242
    v3
  2. Notable Primary completion date: Jan 31, 2029 to Nov 5, 2029
    • Study completion date: Jan 31, 2030 to Nov 5, 2032
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Proportion of eligible first-degree relatives (FDRs) of the affected proband who underwent genetic testing
Timeframe: Within 6 months of proband randomization

Secondary (1)

Proportion of eligible FDRs with a PGV undergoing disease prevention efforts

Arms and interventions

Step 1 (biospecimen collection, genetic testing)Experimental

Probands undergo collection of blood samples and genetic testing on study.

Step 2, Arm A (proband-mediated)Active comparator

FDRs receive proband-mediated communication about the proband's genetic testing results.

Step 2, Arm B (provider-mediated)Experimental

FDRs receive provider-mediated communication about the proband's genetic testing results.

Procedures: Biospecimen Collection

Other: Genetic Testing, Communication Intervention, Survey Administration

Sites

365 sites in 2 countries

United States 358, Puerto Rico 7